Francesca Fallarino

Active 1996–2025

103
Papers
21,772
Citations
73
h-index
101
i10-index

Citations

Citations per year for Francesca Fallarino1996: 2 citations1997: 2 citations1998: 8 citations1999: 22 citations2000: 19 citations2001: 29 citations2002: 72 citations2003: 125 citations2004: 176 citations2005: 199 citations2006: 250 citations2007: 284 citations2008: 295 citations2009: 281 citations2010: 230 citations2011: 225 citations2012: 235 citations2013: 189 citations2014: 278 citations2015: 262 citations2016: 239 citations2017: 298 citations2018: 247 citations2019: 751 citations2020: 996 citations2021: 1,022 citations2022: 796 citations2023: 673 citations2024: 966 citations2025: 525 citations2026: 15 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,569 citing papers, 25.9% of this breakdownChina: 1,658 citing papers, 16.7% of this breakdownItaly: 627 citing papers, 6.3% of this breakdownGermany: 527 citing papers, 5.3% of this breakdownUnited Kingdom: 517 citing papers, 5.2% of this breakdownFrance: 387 citing papers, 3.9% of this breakdownJapan: 276 citing papers, 2.8% of this breakdownCanada: 267 citing papers, 2.7% of this breakdownNetherlands: 254 citing papers, 2.5% of this breakdownAustralia: 241 citing papers, 2.4% of this breakdownSwitzerland: 168 citing papers, 1.7% of this breakdownSpain: 167 citing papers, 1.7% of this breakdown
0%25.9%Other 22.9%

Fields

  • Medicine28.1%
  • Immunology and Microbiology26%
  • Biochemistry, Genetics and Molecular Biology24.7%
  • Neuroscience15.6%
  • Agricultural and Biological Sciences1.3%
  • Environmental Science1.2%
  • Other3.1%

Topics

  • Immune Cell Function and Interaction7.2%
  • Tryptophan and brain disorders6.8%
  • Gut microbiota and health6.5%
  • T-cell and B-cell Immunology4.5%
  • Immunotherapy and Immune Responses4.3%
  • Cancer Immunotherapy and Biomarkers3.4%
  • Other67.3%

Coauthors

All papers

Open in search
  1. Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22

    Authors: , , , , , , , , , , , , - Immunity 2013 cited by 2,435

  2. Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond

    Authors: , , , , - Nature Reviews Drug Discovery 2019 cited by 1,538

  3. Aryl hydrocarbon receptor control of a disease tolerance defence pathway

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Louis Boon, Matteo Pirro, Alfonso Iorio, B. Veyret, Luigina Romani, Ursula Grohmann, Francesca Fallarino, Paolo Puccetti - Nature 2014 cited by 674

  4. T cell apoptosis by tryptophan catabolism

    Authors: , , , , , , , - Cell Death and Differentiation 2002 cited by 1,014

  5. A Relay Pathway between Arginine and Tryptophan Metabolism Confers Immunosuppressive Properties on Dendritic Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Immunity 2017 cited by 343

  6. Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism

    Authors: , , , , , , , , , , , , , - eLife 2021 cited by 125

  7. Modulation of tryptophan catabolism by regulatory T cells

    Authors: , , , , , , , , , - Nature Immunology 2003 cited by 1,337

  8. The Combined Effects of Tryptophan Starvation and Tryptophan Catabolites Down-Regulate T Cell Receptor ζ-Chain and Induce a Regulatory Phenotype in Naive T Cells

    Authors: , , , , , , , , , , , , - The Journal of Immunology 2006 cited by 1,038

  9. Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells

    Authors: , , , , , , , , , , , , , , , , - Nature Immunology 2011 cited by 690

  10. Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re-administration

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2018 cited by 254

  11. Indoleamine 2,3-dioxygenase 1 activation in mature cDC1 promotes tolerogenic education of inflammatory cDC2 via metabolic communication

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Immunity 2022 cited by 115

  12. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1

    Authors: , , , , , , , , , , , , , - Nature Immunology 2003 cited by 872

  13. IDO Upregulates Regulatory T Cells via Tryptophan Catabolite and Suppresses Encephalitogenic T Cell Responses in Experimental Autoimmune Encephalomyelitis

    Authors: , , , , , , , , - The Journal of Immunology 2010 cited by 355

  14. Engagement of Nuclear Coactivator 7 by 3-Hydroxyanthranilic Acid Enhances Activation of Aryl Hydrocarbon Receptor in Immunoregulatory Dendritic Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Frontiers in Immunology 2019 cited by 75

  15. Nrf2 as regulator of innate immunity: A molecular Swiss army knife!

    Authors: , , , , , , , , , , , - Biotechnology Advances 2017 cited by 166

  16. Extracellular Vesicles in Aging: An Emerging Hallmark?

    Authors: , , , , , , , , , , , - Cells 2023 cited by 54

  17. The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions

    Authors: , , , , , - International Journal of Molecular Sciences 2021 cited by 58

  18. CTLA-4–Ig regulates tryptophan catabolism in vivo

    Authors: , , , , , , , , , , - Nature Immunology 2002 cited by 1,137

  19. Tryptophan Metabolites at the Crossroad of Immune-Cell Interaction via the Aryl Hydrocarbon Receptor: Implications for Tumor Immunotherapy

    Authors: , , , , - International Journal of Molecular Sciences 2021 cited by 60

  20. Gut CD103 + dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction

    Authors: , , , , , , , - Gut 2010 cited by 374

  21. Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ursula Grohmann - National Academy of Sciences, Proceedings of the National Academy of Sciences 2020 cited by 83

  22. 3-hydroxy-L-kynurenamine is an immunomodulatory biogenic amine

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Grégoire Lauvau, Chaim Putterman, Kari Alitalo, Ursula Grohmann, Laura Santambrogio - Nature Communications 2021 cited by 62

  23. IL-22 defines a novel immune pathway of antifungal resistance

    Authors: , , , , , , , , , , , - Mucosal Immunology 2010 cited by 267

  24. Targeting indoleamine-2,3-dioxygenase in cancer: Scientific rationale and clinical evidence

    Authors: , , , , , , , , - Pharmacology & Therapeutics 2018 cited by 99